Nanoparticle mRNA Vaccins against Coronavirus and Emerging Variants (Q3989360): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed label, description and/or aliases in en: Adding English translations)
(‎Changed label, description and/or aliases in fr: Adding French translations)
label / frlabel / fr
 
Vaccins à nanoparticules à ARNm contre le coronavirus et les nouvelles variétés

Revision as of 19:53, 13 December 2021

Project Q3989360 in Netherlands
Language Label Description Also known as
English
Nanoparticle mRNA Vaccins against Coronavirus and Emerging Variants
Project Q3989360 in Netherlands

    Statements

    293,087.67 Euro
    0 references
    1,434,730.4 Euro
    0 references
    20.428 percent
    0 references
    1 April 2021
    0 references
    31 March 2023
    0 references
    20Med Therapeutics
    0 references
    0 references

    52°14'25.08"N, 6°51'14.04"E
    0 references
    7522 NB
    0 references

    Identifiers

    OP-2014-2023-Oost-PROJ-01040
    0 references